Identification and characterization of adverse effects in 21st Century toxicology

Toxicological Sciences

Volumn 126, Issue 2, 2012, Pages 291-297

  Keller, Douglas A ^a   Juberg, Daland R ^b   Catlin, Natasha ^c   Farland, William H ^d   Hess, Frederick G ^e   Wolf, Douglas C ^f   Doerrer, Nancy G ^g  

^a SANOFI   (France)

^b DOW AGROSCIENCES LLC   (United States)

^c BROWN UNIVERSITY   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e BASF CORPORATION   (United States)

^f U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^g ILSI HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE   (United States)

Author keywords

Adaptive; Adverse; High data content assays; RPTC; RRR

Indexed keywords

ADAPTATION; ADVERSE DRUG REACTION; ARTICLE; BIOCHEMISTRY; COMPUTER MODEL; CYTOTOXICITY; DECISION MAKING; DOSIMETRY; EXPOSURE; GENOTOXICITY; IN VITRO STUDY; RELEVANT PATHWAY OF TOXICOLOGICAL CONCERN; RELEVANT RESPONSE FOR REGULATION; RISK ASSESSMENT; TOXICITY TESTING; TOXICOLOGY;

ANIMALIA;

EID: 84859082867     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr350     Document Type: Article

References (33)

1. st century: Bringing the vision to life. Toxicol. Sci. 107, 324-330.
2. st century: Moving from discussion to action. Toxicol. Sci. 117, 17-24.
3. Bundesinstitut für Risikobewertung (BfR). (2009). Development of a Stepwise Procedure for the Assessment of Substances with Endocrine Disrupting Properties According to the Plant Protection Products Regulation. Draft Concept Paper. (Reg. (EC) No 1107/2009). German Federal Institute for Risk Assessment.
4. Boekelheide, K., and Andersen, M. E. (2010). A mechanistic redefinition of adverse effects-A key step in the toxicity testing paradigm shift. ALTEX 27, 243-252.
5. st century: Using the new toxicity testing paradigm to create a taxonomy of adverse effects. Toxicol. Sci. 114, 20-24.
6. Boobis, A. R., Cohen, S. M., Dellarco, V., McGregor, D., Meek, M. E., Vickers, C., Willcocks, D., and Farland, W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36, 781-792.
7. st century: A view from the chemical industry. Toxicol. Sci. 112, 297-302.
8. Bushel, P. R., Heinloth, A. N., Li, J., Huang, L., Chou, J. W., Boorman, G. A., Malarkey, D. E., Houle, C. D., Ward, S. M., Wilson, R. E., et al. (2007). Blood gene expression signatures predict exposure levels. Proc. Natl. Acad. Sci. U.S.A. 104, 18211-18216.
9. st century. Toxicol. Sci. 112, 17-22.
10. st century toxicity testing. Toxicol. Sci. 111, 226-232.
11. Crump, K. S., Chen, C., Chiu, W. A., Louis, T. A., Portier, C. J., Subramaniam, R. P., and White, P. D. (2010). What role for biologically based dose-response models in estimating low-dose risk? Environ. Health Perspect. 118, 585-588.
12. Dix, D. J., Houck, K. A., Martin, M. T., Richard, A. M., Setzer, R. W., and Kavlock, R. J. (2007). The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol. Sci. 95, 5-12.
13. Dorato, M. A., and Engelhardt, J. A. (2005). The no-observed-adverse-effectlevel in drug safety evaluations: Use, issues and definition(s). Regul. Toxicol. Pharmacol. 42, 265-264.
14. Fannin, R. D., Russo, M., O'Connell, T. M., Gerrish, K., Winnike, J. H., Macdonald, J., Newton, J., Malik, S., Sieber, S. O., Parker, J., et al. (2010). Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology 51, 227-236.
15. Goetz, A. K., Singh, B. P., Battalora, M., Breier, J. M., Bailey, J. P., Chukwudebe, A. C., and Janus, E. R. (2011). Current and future use of genomics data in toxicology: Opportunities and challenges for regulatory applications. Regul. Toxicol. Pharmacol. 61, 141-153.
16. Goodman, J. E., Dodge, D. G., and Bailey, L. A. (2010). A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide. Regul. Toxicol. Pharmacol. 58, 308-322.
17. st century-Mapping the road ahead. Toxicol. Sci. 109, 18-23.
18. Heinloth, A. N., Irwin, R. D., Boorman, G. A., Nettesheim, P., Fannin, R. D., Sieber, S. O., Snell, M. L., Tucker, C. J., Li, L., Travlos, G. S., et al. (2004). Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci. 80, 193-202.
19. Joint FAO/WHO Meeting on Pesticide Residues (JMPR). (2006). Pesticide residues in food 2006. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group on Pesticide Residues. Rome, Italy, 3-12 October 2006. FAO Plant Production and Protection Paper 187, Section 2.7, page 14. Available at: http://www.fao.org/ag/AGP/AGPP/Pesticid/JMPR/DOWNLOAD/2006_rep/report2006jmpr.pdf. Accessed February 6, 2012.
20. Lewis, R. W., Billington, R., Debryune, E., Garner, A., Lang, B., and Carpanini, F. (2002). Recognition of adverse and nonadverse effects in toxicity studies. Toxicol. Pathol. 30, 66-74.
21. st century: A view from the pharmaceutical industry. Toxicol. Sci. 110, 40-46.
22. st Century in a regulatory context: Another Ames test?... or a new edition of "the Red Book"? Toxicol. Sci. 108, 19-21.
23. NRC. (2007). Toxicity Testing in the Twenty-FirstCentury: A Vision and a Strategy. National Research Council, National Academies Press, Washington, DC.
24. Powell, C.L., Kosyk,O., Ross, P.K., Schoonhoven, R., Boysen, G., Swenberg, J.A., Heinloth, A.N., Boorman, G. A., Cunningham,M. L., Paules, R. S., et al. (2006). Phenotypic anchoring of acetaminophen-induced oxidative stress with gene expression profiles in rat liver. Toxicol. Sci. 93, 213-222.
25. Schmidt, C. W. (2009). TOX21: New dimensions of toxicity testing. Environ. Health Perspect. 117, A349-A353.
26. Sen, B., Wang, A., Hester, S. D., Robertson, J. L., and Wolf, D. C. (2005). Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium. Toxicology 215, 214-226.
27. Sen, B., Wolf, D. C., Turpaz, Y., Bugrim, A., Retief, J., and Hester, S. D. (2007). Identification of interspecies concordance of mechanisms of arsenicinduced bladder cancer. Toxicol. In Vitro 21, 1513-1529.
28. Simmons, S. O., Fan, C.-Y., and Ramabhadran, R. (2009). Cellular stress response pathway system as a sentinel ensemble in toxicological screening. Toxicol. Sci. 111, 202-225.
29. st century toxicology: Outcome of a human toxicology project consortium workshop. Toxicol. Sci. 125, 327-334.
30. Suter, L., Schroeder, S., Meyer, K., Gautier, J.-C., Amberg, A., Wendt, M., Gmuender, H., Mally, A., Boitier, E., Ellinger-Zeigelbauer, H., et al. (2011). EU Framework 6 Project: Predictive Toxicology (PredTox)-Overview and outcome. Toxicol. Appl. Pharmacol. 252, 73-84.
31. U.S. Environmental Protection Agency (USEPA). (2005). Science Issue Paper: Mode of Carcinogenic Action for Cacodylic Acid (Dimethylarsinic acid, DMAv) and Recommendations for Dose Response Extrapolation. Available at http://www.epa.gov/oppsrrd1/reregistration/cacodylic_acid/dma_moa.pdf. Accessed January 20, 2012.
32. U.S. Environmental Protection Agency (USEPA). (2009). Integrated Risk Information System (IRIS) Glossary. Available at: http://www.epa.gov/ncea/iris/help_gloss.htm. Accessed February 6, 2012.
33. st century paradigm for evaluating the health hazards of nanoscale materials. Toxicol. Sci. 110, 251-254.